Home › Funds › Oaktree Capital Management › CYTK
Oaktree Capital Management position in CYTK
CYTOKINETICS INC · Health Care
Latest position (Q4 2024)12.00K sh
Reported value held$14.29K
Portfolio Weight0.03%
First reportedQ4 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 12.00K | $14.29K | New |
Other funds holding CYTK
- BlackRock Inc 20.09M sh · $1.71B · Q2 2026
- Vanguard Group 12.05M sh · $765.54M · Q4 2025
- Geode Capital Management 3.71M sh · $316.33M · Q2 2026
- Citadel Advisors 1.97M sh · $167.55M · Q2 2026
- Capital Research Global Investors 1.69M sh · $143.68M · Q2 2026
- Northern Trust Corp 1.65M sh · $140.34M · Q2 2026
- Point72 Asset Management 1.59M sh · $135.31M · Q2 2026
- Charles Schwab Investment Management 1.57M sh · $133.39M · Q2 2026
- Principal Global Investors 1.31M sh · $111.74M · Q2 2026
- Invesco Ltd 1.24M sh · $105.24M · Q2 2026
- UBS Group AG 1.17M sh · $99.78M · Q2 2026
- D. E. Shaw & Co 1.05M sh · $89.29M · Q2 2026